Pharmacy EssentialsAugust 03, 2026 | Clinical Pharmacology Ambulatory Care Pharmacy (BCACP) Benzodiazepine Use Has Plateaued in Older Adults Benzodiazepine use among U.S. adults aged 65 years and older declined before 2020 but remained largely unchanged through 2024. Long-term use persisted in roughly one-third of users, with smaller reductions among adults aged 75 years and older. Read full article Ambulatory Care Pharmacy (BCACP) ADHD Medication Recalled Due to Incorrect Labeling The FDA issued a Class II recall for an amphetamine-based ADHD medication after a labeling mix-up resulted in immediate-release capsules being packaged as extended release. The recall affects a single lot totaling 1,392 bottles. Read full article Ambulatory Care Pharmacy (BCACP) Pharmacist Interventions at 14 Specialty Pharmacies Avoided $3.6 Million in Costs in 6 Months Across 14 health-system specialty pharmacies, pharmacist interventions were associated with an estimated $3.6 million in avoided medication costs over six months. The analysis used a structured attribution method to assess the likelihood that individual interventions altered treatment trajectories. Read full article Ambulatory Care Pharmacy (BCACP) As Medicare’s GLP-1 Bridge Program Launches, ISMP Offers Guidance for Pharmacists Medicare's new GLP-1 Bridge Program expands lower-cost access to certain weight-loss medications for eligible beneficiaries. Concurrent ISMP guidance outlines common medication errors and counseling challenges as more patients initiate GLP-1 therapy. Read full article Cardiology Profound Hypothyroidism as a Reversible Cause of Severe Low-Density Lipoprotein Cholesterol (LDL-C) Elevation: A Case Report A post-thyroidectomy patient’s LDL-C rose above 250 mg/dL during recurrent hypothyroidism and improved after euthyroidism returned. The case highlights medication adherence and secondary-cause review before lipid-therapy escalation. Read full article